Technology
The world's first home-care therapy delivery and real time monitoring system for people with atrial fibrillation.
Closed loop 24/7 monitoring and preventive therapy
On-going monitoring system for detection and prediction of arrythmia events with cloud based sensor data analysis and personalized algorithms for therapeutic relief.
- Reduces AF Burden
- Restore ANS Balance
- Algorithm Based Neuromodulation (nerve stimulation) Treatment
- PPG/ECG Monitoring
- Cloud Operated AI system
- Algorithm Based Alerts
PPG/ECG Monitoring
Cloud Operated AI system
Algorithm Based Alerts
Algorithm Based Neuromodulation (nerve stimulation) Treatment
Restores ANS Balance
Reduces AF Burden
Previous
Next
Clinical Data
Acute Reduction of PAC’s & Long-tern Reduction in AF recurrence Rates - An 8 week Home-Care Treatment & Monitoring Study
Long term AF recurrence reduction
in an 8 week study
Compared to Hospital & Literature Control CardiaCare reduces long term expected AF recurrence rates after cardioversion
from 38% to 20%.
Acute PAC reduction in individual patients
CardiaCare reduces PAC’s (Premature Atrial Complexes- a well established AF precursor)
by 35%-100% during 30 minutes of neuromodulation sessions. Shown are individual patients
PAC’s in 2 min ECG before Vs. after treatments.
Mean group PAC reduction before Vs. after therapy
A significant mean group acute PAC reduction of 58% observed in treated patients
Creating reassurance of well-being
A seamless device-phone-cloud experience that allows patients and health-care providers remote optimization of care.
Cardia Care
Ease and simplicity of use
Atrial Fibrillation recurrence rates after cardioversion or spontaneous conversion to sinus rhythm are markedly increased by CardiaCare.
Poor response to standard AF care is common and leads to increased episodes of recurrence, hospitalizations and procedures. Human data from CardiaCare labs shows that users experienced less and shorter episodes, reduction of AF related symptoms and increased quality of life.